|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
34,850,000 |
Market
Cap: |
9.17(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1389 - $0.3069 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Applied Molecular Transport is a clinical-stage biopharmaceutical company utilizing its proprietary technology platform to design and develop a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Co. has two oral biologics in clinical development. Co.'s product candidate, AMT-101, is in Phase 2 development for patients with ulcerative colitis and related inflammatory indications. Co.'s second product candidate, AMT-126 is in Phase 1 development for diseases related to intestinal epithelium barrier function defects.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
150,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$149,635 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
1,085,151 |
1,117,888 |
Total Sell Value |
$0 |
$0 |
$175,700 |
$195,444 |
Total People Sold |
0 |
0 |
3 |
6 |
Total Sell Transactions |
0 |
0 |
8 |
25 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kanwar Bittoo |
Chief Medical Officer |
|
2021-12-22 |
4 |
OE |
$2.38 |
$74,970 |
D/D |
31,500 |
31,500 |
|
- |
|
Mrsny Randall Ph.d. |
Chief Scientific Officer |
|
2021-12-09 |
4 |
B |
$14.99 |
$52,464 |
D/D |
3,500 |
3,500 |
2.81 |
- |
|
Epq Llc, Amtc Ps |
Owner |
|
2021-11-17 |
4 |
B |
$22.38 |
$159,684 |
I/I |
7,135 |
8,275,375 |
0.01 |
- |
|
Epq Llc, Amtc Ps |
Owner |
|
2021-11-16 |
4 |
B |
$22.57 |
$90,298 |
I/I |
4,000 |
8,268,240 |
0.01 |
- |
|
Kim Helen Susan |
Director |
|
2021-08-25 |
4 |
AS |
$30.08 |
$285,075 |
D/D |
(9,478) |
590,014 |
|
- |
|
Kim Helen Susan |
Director |
|
2021-08-24 |
4 |
AS |
$30.03 |
$15,255 |
D/D |
(508) |
599,492 |
|
- |
|
Cross Shawn |
Chief Financial Officer |
|
2021-08-23 |
4 |
AS |
$30.12 |
$292,190 |
D/D |
(9,700) |
0 |
|
- |
|
Cross Shawn |
Chief Financial Officer |
|
2021-08-23 |
4 |
OE |
$4.61 |
$44,717 |
D/D |
9,700 |
9,700 |
|
- |
|
Cross Shawn |
Chief Financial Officer |
|
2021-08-19 |
4 |
AS |
$30.01 |
$9,003 |
D/D |
(300) |
0 |
|
- |
|
Cross Shawn |
Chief Financial Officer |
|
2021-08-19 |
4 |
OE |
$4.61 |
$1,383 |
D/D |
300 |
300 |
|
- |
|
Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
|
2021-07-21 |
4 |
S |
$36.41 |
$330,097 |
D/D |
(9,000) |
0 |
|
- |
|
Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
|
2021-07-21 |
4 |
OE |
$4.61 |
$41,490 |
D/D |
9,000 |
9,000 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2021-07-07 |
4 |
AS |
$42.01 |
$315,693 |
D/D |
(7,500) |
0 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2021-07-07 |
4 |
OE |
$2.38 |
$17,850 |
D/D |
7,500 |
7,500 |
|
- |
|
Kim Helen Susan |
Director |
|
2021-07-02 |
4 |
S |
$43.30 |
$8,663,731 |
D/D |
(200,000) |
600,000 |
|
- |
|
Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
|
2021-04-21 |
4 |
S |
$39.30 |
$364,557 |
D/D |
(9,000) |
0 |
|
- |
|
Bhatt Elizabeth |
Chief Bus. & Strategy Officer |
|
2021-04-21 |
4 |
OE |
$4.61 |
$41,490 |
D/D |
9,000 |
9,000 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2021-04-07 |
4 |
S |
$53.48 |
$410,946 |
D/D |
(7,500) |
0 |
|
- |
|
Kanwar Bittoo |
Chief Medical Officer |
|
2021-04-07 |
4 |
OE |
$2.38 |
$17,850 |
D/D |
7,500 |
7,500 |
|
- |
|
Lamond David |
Director |
|
2021-04-06 |
4 |
B |
$42.00 |
$1,050,000 |
I/I |
25,000 |
1,011,019 |
2.1 |
- |
|
Kim Helen Susan |
Director |
|
2020-07-02 |
4 |
OE |
$0.02 |
$16,000 |
D/D |
800,000 |
800,000 |
|
- |
|
Epq Llc, Amtc Ps |
See footnote 7 |
|
2020-06-09 |
4 |
B |
$14.00 |
$38,080,000 |
I/I |
2,720,000 |
8,264,240 |
0.01 |
- |
|
Epq Llc, Amtc Ps |
See footnote 7 |
|
2020-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
5,544,240 |
5,544,240 |
|
- |
|
Founders Fund Vi Principals Fund, Lp |
10% Owner |
|
2020-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
4,438,222 |
757,139 |
|
- |
|
Lamond David |
Director |
|
2020-06-09 |
4 |
A |
$14.00 |
$1,000,020 |
I/I |
71,430 |
986,019 |
|
- |
|
106 Records found
|
|
Page 4 of 5 |
|
|